Amir Nashat

Affiliations

  • at Scholar Rock Holding Corp (SRRK), 2023-12-29
  • Director at Morphic Holding Inc. (MORF), 2023-06-30
  • Large Shareholder, Director at Metacrine Inc. (MTCR), 2022-09-06
  • Director at Syros Pharmaceuticals Inc. (SYRS), 2022-06-02
  • Director at Fate Therapeutics Inc (FATE), 2019-08-02
  • Director at Selecta Biosciences Inc (SELB), 2019-06-18
  • Director at Atyr Pharma Inc (LIFE), 2018-05-17
  • Director at Bind Therapeutics Inc (BIND), 2015-06-10
  • Director at Receptos Inc. (RCPT), 2014-06-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SRRK $4.90 66,142 Director 206,897 2022-06-22 Filing
SRRK $4.90 1,131,850 Director 3,540,530 2022-06-22 Filing
MTCR $13.00 15,038 Large Shareholder, Director 15,038 2020-09-18 Filing
MTCR $13.00 214,962 Large Shareholder, Director 214,962 2020-09-18 Filing
MORF $15.00 8,173 Director 151,879 2019-07-01 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MORF $45.50 15,188 Director 136,691 2021-05-21 Filing
MORF $45.50 217,107 Director 1,953,960 2021-05-21 Filing
FATE $22.53 299 Director 11,034 2019-08-01 Filing
FATE $22.53 302 Director 11,333 2019-07-31 Filing
FATE $22.53 204 Director 7,539 2019-08-01 Filing